Rijksvaccinatieprogramma LIM cohortstudie 2: HPV monitor

Study identification

• EU PAS number:
  EUPAS46107
• Study ID:
  46108
• Official title and acronym:
  Rijksvaccinatieprogramma LIM cohortstudie 2: HPV monitor
• DARWIN EU® study:
  No
• Study countries:
  Netherlands
• Study status:
  Planned

Research institutions and networks

Institutions

Netherlands Pharmacovigilance Centre Lareb

Netherlands

Study timelines

Date when funding contract was signed

Planned: 01/02/2022

Actual: 01/02/2022

Study start date

Planned: 01/04/2022

Date of final study report

Planned: 31/03/2025

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Dutch Ministry of Health, Welfare and Sports

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

www.hpvmonitor.nl